Teleflex Inc (TFX):企業の財務・戦略的SWOT分析

◆英語タイトル:Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15491
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Teleflex Inc (TFX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teleflex Inc (Teleflex) designs, develops, manufactures, and distributes disposable medical devices for use in critical care and surgery. Its major products include circuits, masks and bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptor and connectors. The company’s products find application in fields such as vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex markets its products to hospitals, healthcare providers, distributors, and original equipment manufacturers through internal sales force, independent representatives and independent distributor networks. The company operates in the Americas, Europe, the Middle East, Africa and Asia. Teleflex is headquartered in Wayne, Pennsylvania, the US.

Teleflex Inc Key Recent Developments

Mar 14,2019 Teleflex Announces Attendance and Poster Presentation at the Annual European Association of Urology Meeting
Feb 21,2019 Teleflex reports fourth quarter and full year 2018 results; provides 2019 guidance
Feb 20,2019 Teleflex awarded SURPASS agreement with Premier
Feb 04,2019 Teleflex Announces U.S. FDA Premarket Approval of MANTA Vascular Closure Device

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Teleflex Inc – Key Facts
Teleflex Inc – Key Employees
Teleflex Inc – Key Employee Biographies
Teleflex Inc – Major Products and Services
Teleflex Inc – History
Teleflex Inc – Company Statement
Teleflex Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Teleflex Inc – Business Description
Business Segment: All Other
Overview
Performance
Business Segment: Anesthesia North America
Overview
Performance
Business Segment: Asia
Overview
Business Segment: Europe, the Middle East and Africa (EMEA)
Overview
Performance
Business Segment: Interventional North America
Overview
Performance
Business Segment: OEM
Overview
Performance
Business Segment: Surgical North America
Overview
Performance
Business Segment: Vascular North America
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Asia and Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
R&D Overview
Teleflex Inc – Corporate Strategy
Teleflex Inc – SWOT Analysis
SWOT Analysis – Overview
Teleflex Inc – Strengths
Teleflex Inc – Weaknesses
Teleflex Inc – Opportunities
Teleflex Inc – Threats
Teleflex Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teleflex Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Teleflex Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Teleflex Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 14, 2019: Teleflex Announces Attendance and Poster Presentation at the Annual European Association of Urology Meeting
Feb 21, 2019: Teleflex reports fourth quarter and full year 2018 results; provides 2019 guidance
Feb 20, 2019: Teleflex awarded SURPASS agreement with Premier
Feb 04, 2019: Teleflex Announces U.S. FDA Premarket Approval of MANTA Vascular Closure Device
Nov 01, 2018: Teleflex reports third quarter 2018 results
Oct 29, 2018: Teleflex Receives 2018 Medical Design Excellence Award (MDEA) for Arrow AC3 OptimusTM Intra-Aortic Balloon Pump
Oct 29, 2018: NeoTract Receives Phoenix 2018 Emerging Growth Company Award for Outstanding Industry Achievement
Oct 24, 2018: NeoTract Welcomes UK Government Announcement to Remove Barriers to Adoption of the UroLift System for BPH Care for Every NHS Hospital in England
Oct 05, 2018: Teleflex buys vascular closure device manufacturer Essential Medical
Sep 26, 2018: NeoTract gibt Ergebnisse aus zwei Studien zu den transformativen Vorteilen des UroLift® -Systems in der BPH-Versorgung bekannt
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Teleflex Inc, Key Facts
Teleflex Inc, Key Employees
Teleflex Inc, Key Employee Biographies
Teleflex Inc, Major Products and Services
Teleflex Inc, History
Teleflex Inc, Other Locations
Teleflex Inc, Subsidiaries
Teleflex Inc, Key Competitors
Teleflex Inc, Ratios based on current share price
Teleflex Inc, Annual Ratios
Teleflex Inc, Annual Ratios (Cont...1)
Teleflex Inc, Annual Ratios (Cont...2)
Teleflex Inc, Interim Ratios
Teleflex Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Teleflex Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Teleflex Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Teleflex Inc, Performance Chart (2014 - 2018)
Teleflex Inc, Ratio Charts
Teleflex Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Teleflex Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Teleflex Inc (TFX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baloise Belgium NV:企業の戦略・SWOT・財務分析
    Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report Summary Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Australian Broadcasting Corp:企業の戦略的SWOT分析
    Australian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pilatus Group:企業の戦略・SWOT・財務情報
    Pilatus Group - Strategy, SWOT and Corporate Finance Report Summary Pilatus Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oman Air (SAOC):企業の戦略・SWOT・財務情報
    Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report Summary Oman Air (SAOC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vanderbilt University:製薬・医療:M&Aディール及び事業提携情報
    Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as c …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and …
  • Kimball International, Inc. (KBAL):企業の財務・戦略的SWOT分析
    Kimball International, Inc. (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Denka Company Ltd:企業の戦略・SWOT・財務分析
    Denka Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Denka Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析
    Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Vanguard Natural Resources, Inc (Vanguard) is an independent oil and gas company with upstream operations. It acquires, produces, and develops oil and natural gas properties. The compa …
  • Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Wacker Neuson Se
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Veeco Instruments Inc (VECO):企業の財務・戦略的SWOT分析
    Summary Veeco Instruments Inc (Veeco) is a technology company that designs, manufacture and markets thin film and semiconductor equipment. The company offers various products and technologies which include MOCVD systems, precision surface processing system, MBE technologies, and ion beam sputtering. …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Scandinavian Biopharma Holding AB (Scandinavian) is a biotechnology company that distributes vaccines and immunoglobulin. The company offers diagnostics, vaccines, dental and immunoglobulin products. Its products are used in the therapeutic areas of diphtheria and tetanus, tuberculosis, poli …
  • Hemispherx Biopharma Inc (HEB):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆